NO953089D0 - Steroider for behandling av menopausale plager - Google Patents

Steroider for behandling av menopausale plager

Info

Publication number
NO953089D0
NO953089D0 NO953089A NO953089A NO953089D0 NO 953089 D0 NO953089 D0 NO 953089D0 NO 953089 A NO953089 A NO 953089A NO 953089 A NO953089 A NO 953089A NO 953089 D0 NO953089 D0 NO 953089D0
Authority
NO
Norway
Prior art keywords
menopausal
ailments
steroids
treatment
menopausal ailments
Prior art date
Application number
NO953089A
Other languages
English (en)
Other versions
NO953089L (no
NO308583B1 (no
Inventor
Hubert Jan Josef Loozen
Lodewijk Pieter Cornelis Schot
Jane Margretha Le Werf-Pieters
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO953089D0 publication Critical patent/NO953089D0/no
Publication of NO953089L publication Critical patent/NO953089L/no
Publication of NO308583B1 publication Critical patent/NO308583B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007—Cyclic thioketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO953089A 1993-02-08 1995-08-07 Anvendelse av steroider for fremstilling av et medikament for behandling av forstyrrelser indusert av østrogenmangel, steroidene samt farmasøytisk blanding NO308583B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93200332 1993-02-08
PCT/EP1994/000348 WO1994018224A1 (en) 1993-02-08 1994-02-04 Steroids for treating menopausal complaints

Publications (3)

Publication Number Publication Date
NO953089D0 true NO953089D0 (no) 1995-08-07
NO953089L NO953089L (no) 1995-10-06
NO308583B1 NO308583B1 (no) 2000-10-02

Family

ID=8213615

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953089A NO308583B1 (no) 1993-02-08 1995-08-07 Anvendelse av steroider for fremstilling av et medikament for behandling av forstyrrelser indusert av østrogenmangel, steroidene samt farmasøytisk blanding

Country Status (15)

Country Link
EP (1) EP0682672A1 (no)
JP (1) JPH08506116A (no)
KR (1) KR100364113B1 (no)
CN (1) CN1046735C (no)
AU (1) AU4675897A (no)
BR (1) BR9405825A (no)
CA (1) CA2155532A1 (no)
FI (1) FI114101B (no)
HU (2) HU220615B1 (no)
NO (1) NO308583B1 (no)
NZ (1) NZ261581A (no)
PL (1) PL182901B1 (no)
RU (1) RU2172740C2 (no)
WO (1) WO1994018224A1 (no)
ZA (1) ZA94715B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
ID25621A (id) * 1998-03-09 2000-10-19 Akzo Nobel Nv Perlengkapan kontrasepsi baru
MXPA02001831A (es) 1999-09-06 2002-10-23 Akzo Nobel Nv Esteroides estrogenicos no aromaticos con un sustituyente de hidrocarburo en posicion 11.
AU8201601A (en) 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
ES2881336T3 (es) * 2016-03-03 2021-11-29 Crystal Pharma Sau Procedimiento y nuevos productos intermedios para la preparación de 11-metilen-esteroides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325520A (en) * 1965-12-08 1967-06-13 Searle & Co (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
NL175063C (nl) * 1972-12-09 1984-09-17 Akzo Nv Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
FI54128C (fi) * 1972-12-09 1978-10-10 Akzo Nv Foerfarande foer framstaellning av nya 11,11-alkylidensteroider ur oestran- och 19-norpregnanserien med foerbaettrad hormonell verkan
NL7317358A (nl) * 1973-12-19 1975-06-23 Akzo Nv Nieuwe 11(beta)-alkylsteroiden van de oestraanreeks.
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
AU532512B2 (en) * 1979-09-07 1983-10-06 Upjohn and Horton Anti-allergenic compounds for bone mineral resorption
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
NL8502571A (nl) * 1985-09-20 1987-04-16 Akzo Nv Steroiden met immunomodulerende eigenschappen.
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
DK0461290T3 (da) * 1990-06-14 1994-02-21 Henning Berlin Gmbh Væskefyldte stikkapsler
AU8166191A (en) * 1990-08-10 1992-02-13 Ortho Pharmaceutical Corporation Method for treatment of bone wasting diseases

Also Published As

Publication number Publication date
HU0102320D0 (en) 2001-08-28
NO953089L (no) 1995-10-06
RU2172740C2 (ru) 2001-08-27
WO1994018224A1 (en) 1994-08-18
HUT72971A (en) 1996-06-28
HU220615B1 (hu) 2002-03-28
BR9405825A (pt) 1995-12-05
NZ261581A (en) 1997-06-24
HU9501940D0 (en) 1995-09-28
FI953747A (fi) 1995-09-12
FI114101B (fi) 2004-08-13
PL310125A1 (en) 1995-11-27
FI953747A0 (fi) 1995-08-07
CN1046735C (zh) 1999-11-24
PL182901B1 (pl) 2002-03-29
NO308583B1 (no) 2000-10-02
ZA94715B (en) 1994-10-24
AU4675897A (en) 1998-02-19
JPH08506116A (ja) 1996-07-02
CN1117735A (zh) 1996-02-28
EP0682672A1 (en) 1995-11-22
AU682170B2 (en) 1997-09-25
CA2155532A1 (en) 1994-08-18
AU6039494A (en) 1994-08-29
KR100364113B1 (ko) 2003-04-08

Similar Documents

Publication Publication Date Title
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
AU5750796A (en) System for the treatment of insomnia
BR9306619A (pt) Glicosídeos esteroidais para o tratamento da hipercolesterolemia
HK1042475A1 (zh) 用於治療炎癥的取代噻唑
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
NO953443D0 (no) Fremgangsmåte for behandling av fast avfall
FI962370A (fi) Laite tissuen valmistamiseksi
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO953089D0 (no) Steroider for behandling av menopausale plager
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO982562D0 (no) Sammensetning for behandling av smerte
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
NO945001D0 (no) Steroide glykosider for behandling av hyperkolestrolemi
NO984190D0 (no) Fremgangsmåte for behandling av insomnia
NO964291D0 (no) Fremgangsmåte for behandling av allergisk rinitt